Literature DB >> 30615805

Comparative efficacy of valnoctamide and sec-butylpropylacetamide (SPD) in terminating nerve agent-induced seizures in pediatric rats.

Kari M Haines1, Liana M Matson1, Emily N Dunn1, Cherish E Ardinger1, Robyn Lee-Stubbs2, David Bibi3, John H McDonough1, Meir Bialer3,4.   

Abstract

OBJECTIVES: Children and adults are likely to be among the casualties in a civilian nerve agent exposure. This study evaluated the efficacy of valnoctamide (racemic-VCD), sec-butylpropylacetamide (racemic-SPD), and phenobarbital for stopping nerve agent seizures in both immature and adult rats.
METHODS: Female and male postnatal day (PND) 21, 28, and 70 (adult) rats, previously implanted with electroencephalography (EEG) electrodes were exposed to seizure-inducing doses of the nerve agents sarin or VX and EEG was recorded continuously. Five minutes after seizure onset, animals were treated with SPD, VCD, or phenobarbital. The up-down method was used over successive animals to determine the anticonvulsant median effective dose (ED50 ) of the drugs.
RESULTS: SPD-ED50 values in the VX model were the following: PND21, 53 mg/kg (male) and 48 mg/kg (female); PND28, 108 mg/kg (male) and 43 mg/kg (female); and PND70, 101 mg/kg (male) and 40 mg/kg (female). SPD-ED50 values in the sarin model were the following: PND21, 44 mg/kg (male) and 28 mg/kg (female); PND28, 79 mg/kg (male) and 34 mg/kg (female); and PND70, 53 mg/kg (male) and 53 mg/kg (female). VCD-ED50 values in the VX model were the following: PND21, 34 mg/kg (male) and 43 mg/kg (female); PND28, 165 mg/kg (male) and 59 mg/kg (female); and PND70, 87 mg/kg (male) and 91 mg/kg (female). VCD-ED50 values in the sarin model were the following: PND21, 45 mg/kg (male), 48 mg/kg (female); PND28, 152 mg/kg (male) 79 mg/kg (female); and PND70, 97 mg/kg (male) 79 mg/kg (female). Phenobarbital-ED50 values in the VX model were the following: PND21, 43 mg/kg (male) and 18 mg/kg (female); PND28, 48 mg/kg (male) and 97 mg/kg (female). Phenobarbital-ED50 values in the sarin model were the following: PND21, 32 mg/kg (male) and 32 mg/kg (female); PND28, 58 mg/kg (male) and 97 mg/kg (female); and PND70, 65 mg/kg (female). SIGNIFICANCE: SPD and VCD demonstrated anticonvulsant activity in both immature and adult rats in the sarin- and VX-induced status epilepticus models. Phenobarbital was effective in immature rats, whereas in adult rats, higher doses were required that were accompanied by toxicity. Overall, significantly less drug was required to stop seizures in PND21 animals than in the older animals, and overall, males required higher amounts of drug than females. Wiley Periodicals, Inc.
© 2019 International League Against Epilepsy.

Entities:  

Keywords:  VX; nerve agents; pediatric rats; sarin; sec-butylpropylacetamide; status epilepticus (SE); valnoctamide; valproic acid CNS-active amide derivatives

Year:  2019        PMID: 30615805      PMCID: PMC6419725          DOI: 10.1111/epi.14630

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  26 in total

Review 1.  Epileptogenesis in the immature brain: emerging mechanisms.

Authors:  Sanjay N Rakhade; Frances E Jensen
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

2.  Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine.

Authors:  Tsung-Ming Shih; Tami C Rowland; John H McDonough
Journal:  J Pharmacol Exp Ther       Date:  2006-10-02       Impact factor: 4.030

3.  Anticonvulsant action of GABAB receptor positive modulator CGP7930 in immature rats.

Authors:  Pavel Mareš
Journal:  Epilepsy Res       Date:  2012-02-15       Impact factor: 3.045

4.  Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs.

Authors:  John H McDonough; Joseph D McMonagle; Tsung-Ming Shih
Journal:  Drug Chem Toxicol       Date:  2010-07       Impact factor: 3.356

5.  Anticonvulsants for soman-induced seizure activity.

Authors:  T Shih; J H McDonough; I Koplovitz
Journal:  J Biomed Sci       Date:  1999 Mar-Apr       Impact factor: 8.410

6.  A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.

Authors:  H Steve White; Anitha B Alex; Amanda Pollock; Naama Hen; Tawfeeq Shekh-Ahmad; Karen S Wilcox; John H McDonough; James P Stables; Dan Kaufmann; Boris Yagen; Meir Bialer
Journal:  Epilepsia       Date:  2011-12-09       Impact factor: 5.864

7.  Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels.

Authors:  Meir Bialer; Roy E Twyman; H Steve White
Journal:  Epilepsy Behav       Date:  2004-12       Impact factor: 2.937

Review 8.  Susceptibility of immature and adult brains to seizure effects.

Authors:  Sheryl R Haut; Jana Velísková; Solomon L Moshé
Journal:  Lancet Neurol       Date:  2004-10       Impact factor: 44.182

9.  A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus.

Authors:  W Pouliot; M Bialer; N Hen; T Shekh-Ahmad; D Kaufmann; B Yagen; K Ricks; B Roach; C Nelson; F E Dudek
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

10.  Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.

Authors:  Dan Kaufmann; Meir Bialer; Jakob Avi Shimshoni; Marshall Devor; Boris Yagen
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

View more
  1 in total

1.  Phenobarbital as alternate anticonvulsant for organophosphate-induced benzodiazepine-refractory status epilepticus and neuronal injury.

Authors:  Doodipala Samba Reddy; Dheepthi Perumal; Victoria Golub; Andy Habib; Ramkumar Kuruba; Xin Wu
Journal:  Epilepsia Open       Date:  2020-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.